Funding Round
China's NeuroXess raises $40M Series B for first domestic wireless cortical BCI
Caixin Global3/9/2026·03/09/26🌐 Asia
Summary
Shanghai-based NeuroXess secured ¥290M ($40M) Series B from Qiming Venture Partners, IDG Capital, and government-linked Guotai Junan. The company implanted China's first domestic wireless cortical BCI in a human patient in January 2024, achieving ALS patient control of a computer interface using motor imagery in a landmark domestic clinical demonstration.
Why it matters
China's first domestic wireless cortical BCI patient represents a geopolitical milestone in the race between Chinese and US neurotech. NeuroXess's NMPA regulatory pathway is well-established and domestic competition to Neuralink is now clearly underway.
#Asia#BCI#China#Industry#Neural Interfaces#Venture Capital
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in